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Dr Ronald Dalman (Palo Alto, Calif). If I understand your
presentation correctly, it looks like STAT [signal transducer and
activator of transcription] expression is protective against aneu-
rysm progression; the double knockout seems to increase the rate
of enlargement. This seems somewhat contradictory to the hy-
pothesis that led you to explore this mechanism in the first place.
Perhaps you can comment on this apparent discrepancy?
DrMatthew J. Eagleton. Absolutely. When I started initially
evaluating STAT1,my hypothesis was that loss of STAT1would be
associated with aneurysm inhibition. That hypothesis proved to be
false and the opposite to be true. Some of our cellular work, not
presented here, demonstrates that if we inhibit STAT1 in smooth
muscle cells and macrophages, we see increased MMP [matrix
metalloproteinase] expression and activity in those cells in response
to stimulation, and so STAT1 may have a protective role in some
way by inhibiting MMP expression.
I am not sure though in this model if it is just through
regulation of MMP expression that STAT1 is working. I am
concerned with the acuity with which the dissections occur, and we
are considering that there may be some architectural alteration in
the aortic wall associated with the loss of STAT1. We have not,
however, been able to identify that alteration that would make the
aorta in these double knockout mice more susceptible to an aortic
dissection.
Dr Dalman. Do you use a normal chow diet or a high-fat
chow diet?
Dr Eagleton. These mice are all on a normal chow diet.
Dr Dalman. And the cellularity; is there a difference at all in
the inflammatory cell infiltrate (macrophages/neutrophils) thatDr Eagleton. We have not yet done the morphometric anal-
ysis to look at cell numbers.
Dr Anton Sidawy (Washington, DC). The STATs are tran-
scription activators that get phosphorylated in the cytoplasm but
then move to the nucleus to exert their effect on the gene. Are
there any published data that indicate that this process can get
altered leading to formation of aneurysms in human?
Dr Eagleton. Not in humans. Most of the work done in
humans to date, except for one article that begins to investigate its
role in atherosclerosis, has been done in tumor biology.
Dr Sidawy. And why the female gender is protective?
Dr Eagleton. It’s a great question and I don’t know.
Dr B. Timothy Baxter (Omaha, Neb). One of the things
about the animal models is that findings may be irrelevant to our
patients. You started with the patient tissue, you found a protein of
interest, and then looked at an animal model to see what this
protein is doing. And you found out it was doing something quite
different than what you thought. Beginning with human tissue is
essential to assure relevance of work done in animal models. So I
want to congratulate you on that. We now know that there are
many gene knockout mice that don’t get aneurysms. So my ques-
tion is how are we going to find out which of these proteins are
really critical?
Dr Eagleton. Great question. I think what we may ultimately
have to do is look at a number of these knockout mice, perhaps do
an array analysis on them, and see if there are any downstream
effects that are similar between all of the mice that don’t form
aneurysms and is there a distal common pathway, or pathways, that
are being affected and perhaps that is the area that needs to be
focused on, or several pathways that need to be focused on.
